MEDBOT-B 02252·

Gross margin --------42.74%--30.38%12.37%14.05%16.33%33.52%19.47%48.38%14.87% Net margin ---------27186.37%---5306.13%21880.24%-978.59%4327.54%-251.55%727.05%-46.11%205.43% ROE -152.68%---105.10%47.59%-24.36%80.74%-80.40%56.04%-194.84%114.44%-230.91%36.07%-60.79%170.12% ROA ---------20.94%---59.39%38.45%-71.68%12.29%-50.59%21.09%-19.04%31.55% Revenue growth ------------904.79%--384.15%520.64%145.95%238.20%114.22%31.74% Attributable profit growth -----26.17%---60156865.94%60156839.77%-95.53%60156770.41%11.20%106.73%36.53%25.33%61.14%24.60% Debt-to-assets --------14.39%--27.06%12.67%64.86%37.80%79.85%14.99%70.03%9.82% Current ratio 0.65--0.980.338.937.963.385.551.162.221.700.542.300.60 Operating cash flow / net profit --------0.92--0.780.140.550.230.460.090.090.37 Operating cash flow / revenue ---------25138.88%---4159.03%20979.85%-542.91%3616.12%-115.89%427.02%-4.13%111.76%

Revenue --------2.15M--21.60M904.79%104.59M384.15%257.25M145.95%551.07M114.22% Other income and gains --------24.68M------------------ Gross profit --------919.00K--6.56M614.04%14.69M123.93%86.22M486.77%266.62M209.23% Selling and distribution expenses --------79.19M--184.04M132.41%238.43M29.55%207.93M12.79%203.61M2.08% Administrative expenses --------107.48M--170.47M58.61%126.36M25.88%55.28M56.25%45.64M17.45% Net finance costs --------5.43M--11.37M109.13%18.59M63.56%21.64M16.40%19.81M8.46% Operating profit ---------551.70M---1.10B98.53%-975.14M10.97%-488.75M49.88%-235.26M51.86% Profit before tax ---------584.51M---1.15B96.11%-1.02B10.71%-647.10M36.78%-254.12M60.73% Net profit -768---96926.17%-584.51M60320539.83%-1.15B96.11%-1.02B10.71%-647.10M36.78%-254.12M60.73% Net profit attributable to owners ---------582.92M---1.14B95.53%-1.01B11.20%-642.41M36.53%-249.66M61.14%

Cash and cash equivalents 643--6036.22%1.94B321861425.70%747.96M61.46%507.71M32.12%612.23M20.59%636.32M3.93% Trade and bills receivables --------24.95M--93.72M275.58%55.75M40.52%92.83M66.52%263.76M184.12% Inventories 0--0--109.88M--250.48M127.95%229.50M8.37%151.48M34.00%131.69M13.07% Total current assets 601--89949.58%2.09B232950511.79%1.10B47.53%794.05M27.74%856.55M7.87%1.04B20.90% Total assets --------2.79B--1.93B30.87%1.43B26.02%1.28B10.43%1.33B4.34% Total current liabilities 927--9210.65%234.47M25457989.03%325.31M38.74%685.28M110.65%503.46M26.53%450.19M10.58% Total liabilities --------401.73M--522.25M30.00%926.15M77.34%1.02B10.28%934.67M8.49% Equity attributable to owners 503--92283.30%2.39B259559769.85%1.42B40.76%519.48M63.36%278.20M46.45%410.67M47.62% Total equity 509--92481.53%2.39B258674358.87%1.41B41.10%501.75M64.36%257.68M48.64%399.93M55.20%

Net cash from operating activities ---------540.49M---898.48M66.23%-567.84M36.80%-298.12M47.50%-22.74M92.37% Net cash from investing activities ---------396.57M---267.82M32.47%-58.38M78.20%-47.60M18.47%2.62M105.51% Net cash from financing activities --------1.39B---27.95M102.01%385.68M1480.08%449.96M16.67%49.73M88.95% Net change in cash --------455.18M---1.19B362.37%-240.55M79.86%104.23M143.33%29.60M71.60%